The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Matveeva N.Yu.

Pacific State Medical University

Pavlush D.G.

Pacific State Medical University

Kalinichenko S.G.

Pacific State Medical University

Morphogenesis and molecular regulation of polyposis rhinosinusitis

Authors:

Matveeva N.Yu., Pavlush D.G., Kalinichenko S.G.

More about the authors

Read: 1093 times


To cite this article:

Matveeva NYu, Pavlush DG, Kalinichenko SG. Morphogenesis and molecular regulation of polyposis rhinosinusitis. Russian Journal of Archive of Pathology. 2025;87(1):68‑76. (In Russ.)
https://doi.org/10.17116/patol20258701168

Recommended articles:
Preoperative protective preparation of the nasal mucosa of rhinological patients. Russian Bulletin of Otorhinolaryngology. 2024;(5):23-28

References:

  1. Kato A, Schleimer RP, Bleier BS. Mechanisms and pathogenesis of chronic rhinosinusitis. J Allergy Clin Immunol. 2022;149(5):1491-1503. https://doi.org/10.1016/j.jaci.2022.02.016
  2. Savlevich EL, Zurochka AV, Kurbacheva OM, Egorov VI, Shilovskii IP, Mitrofanova ES, Lyubimova EV. Pleiomorfizm tsitokinovogo profilya v tkani polipov v zavisimosti ot fenotipa polipoznogo rinosinusita. Russian Bulletin of Otorhinolaryngology. 2023;88(1):50-56. (In Russ.). https://doi.org/10.17116/otorino20228801150
  3. Wang W, Gao Y, Zhu Z, Zha Y, Wang X, Qi F, Zhou L, Pang J, Gao Z, Lv W. Changes in the clinical and histological characteristics of Chinese chronic rhinosinusitis with nasal polyps over 11 years. Int Forum Allergy Rhinol. 2019;9(2):149-157.  https://doi.org/10.1002/alr.22234
  4. Huriyati E, Darwin E, Yanwirasti Y, Wahid I. Differences in expression of inflammatory mediator in mucosal and polyp tissue between chronic rhinosinusitis and recurrent chronic rhinosinusitis. Open Access Maced J Med Sci. 2019;7(11):1733-1738. https://doi.org/10.3889/oamjms.2019.341
  5. Pavlush DG, Matveeva NYu. Lokalizatsiya NO-sintazy i malykh apoptoticheskikh molekul v slizistoi obolochke polosti nosa pri polipoznom rinosinusite. Pacific Medical Journal. 2022;(3):63-69. (In Russ.). https://doi.org/10.34215/1609-1175-2022-3-63-69
  6. Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl. S29):1-464.  https://doi.org/10.4193/Rhin20.600
  7. Egorov VI, Kurbacheva OM, Savlevich EL, Shachnev KN, Dyneva ME, Savushkina EYu, Kondakov AK. Opyt raboty tsentra diagnostiki i lecheniya polipoznogo rinosinusita. Rossiiskaya Otorinolaringologiya. 2020;19(6):8-15. (In Russ.). https://doi.org/10.18692/1810-4800-2020-6-8-15
  8. Takabayashi T, Schleimer RP. Formation of nasal polyps: the roles of innate type 2 inflammation and deposition of fibrin. J Allergy Clin Immunol. 2020;145(3):740-750.  https://doi.org/10.1016/j.jaci.2020.01.027
  9. Li X, Li C, Zhu G, Yuan W, Xiao ZA. TGF-β1 induces epithelial-mesenchymal transition of chronic sinusitis with nasal polyps through MicroRNA-21. Int Arch Allergy Immunol. 2019;179(4):304-319.  https://doi.org/10.1159/000497829
  10. Brescia G, Alessandrini L, Giacomelli L, Parrino D, Zanotti C, Tealdo G, Franz L, Carraro V, Barion U, Marioni G. A classification of chronic rhinosinusitis with nasal polyps based on structured histopathology. Histopathology. 2020;76(2):296-307.  https://doi.org/10.1111/his.13969
  11. Matveeva NYu, Pavlush DG, Kalinichenko SG. BMP-2 i IL-1β kak markery vospaleniya slizistoi obolochki polosti nosa pri polipoznom rinosinusite. Bulletin of Experimental Biology and Medicine. 2022;174(10):462-467. (In Russ.). https://doi.org/10.1007/s10517-023-05728-y
  12. Cho SH, Hamilos DL, Han DH, Laidlaw TM. Phenotypes of chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2020;8(5): 1505-1511. https://doi.org/10.1016/j.jaip.2019.12.021
  13. Nakayama T, Haruna SI. A review of current biomarkers in chronic rhinosinusitis with or without nasal polyps. Expert Rev Clin Immunol. 2023;19(8):883-892.  https://doi.org/10.1080/1744666X.2023.2200164
  14. Gao XW, Zhang XM, Liu HY, Wang SS, Dong HJ. Mechanism of interaction between ocular and nasal neurogenic inflammation in allergic rhinoconjunctivitis. Int Ophthalmol. 2019;39(10):2283-2294. https://doi.org/10.1007/s10792-018-01066-5
  15. Enache I, IoniȚĂ E, Mitroi M, Anghelina F, MogoantĂ C, Ciolofan S, CĂpitĂnescu A, Stepan A, Simionescu C. Histopathological features of chronic rhinosinusitis with nasal allergic polyps. Curr Health Sci J. 2020;46(1):66-71.  https://doi.org/10.12865/CHSJ.46.01.09
  16. Matveeva NYu, Pavlush DG, Kalinichenko SG. Ehkspressiya pro- i antiapoptoticheskikh molekul v slizistoi obolochke polosti nosa pri polipoznom rinosinusite. Vestnik Otorinolaringologii. 2020;85(3):43-47. (In Russ.). https://doi.org/10.17116/otorino20208503143
  17. Ryu G, Kim DW. Th2 inflammatory responses in the development of nasal polyps and chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2020;20(1):1-8.  https://doi.org/10.1097/ACI.0000000000000588
  18. Ozcan C, Ismi O, Kara T, Polat G, Erdogan O, Balci Fidanci S, Vayisoglu Y, Gorur K. Is there any possible role of Neurotrophin 3 in the pathogenesis of antrochoanal polyp? Medeni Med J. 2020;35(1):40-46.  https://doi.org/10.5222/MMJ.2020.78889
  19. Klingler AI, Stevens WW, Tan BK, et al. Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps. J Allergy Clin Immunol. 2021;147(4):1306-1317. https://doi.org/10.1016/j.jaci.2020.11.037
  20. Zhu M, Gao X, Zhu Z, Hu X, Zhou H, Liu J. The roles of nasal nitric oxide in diagnosis and endotypes of chronic rhinosinusitis with nasal polyps. J Otolaryngol Head Neck Surg. 2020;49(1):68.  https://doi.org/10.1186/s40463-020-00465-y
  21. Lucas BR, Voegels RL, do Amaral JB, Bachi ALL, Pezato R. BMP-7, MMP-9, and TGF-β tissue remodeling proteins and their correlations with interleukins 6 and 10 in chronic rhinosinusitis. Eur Arch Otorhinolaryngol. 2021;278(11):4335-4343. https://doi.org/10.1007/s00405-021-06722-8
  22. Xu X, Lai Y, Hua ZC. Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep. 2019;39(1):BSR20180992. https://doi.org/10.1042/BSR20180992
  23. Bankova LG, Barrett NA. Epithelial cell function and remodeling in nasal polyposis. Ann Allergy Asthma Immunol. 2020;124(4):333-341.  https://doi.org/10.1016/j.anai.2020.01.018
  24. Lonergan A, Theoharides T, Tsilioni E, Rebeiz E. Substance P and Hemokinin 1 in nasal lavage fluid of patients with chronic sinusitis and nasal polyposis. OTO Open. 2019;3(3):2473974X19875076. https://doi.org/10.1177/2473974X19875076
  25. Zhou Y, Chen R, Kong L, Sun Y, Deng J. Neuroimmune communication in allergic rhinitis. Front Neurol. 2023;14:1282130. https://doi.org/10.3389/fneur.2023.1282130
  26. Jiao J, Wang C, Zhang L. Epithelial physical barrier defects in chronic rhinosinusitis. Expert Rev Clin Immunol. 2019;15(6):679-688.  https://doi.org/10.1080/1744666X.2019.1601556
  27. Carsuzaa F, Béquignon É, Dufour X, de Bonnecaze G, Lecron JC, Favot L. Cytokine signature and involvement in chronic rhinosinusitis with nasal polyps. Int J Mol Sci. 2021;23(1):417.  https://doi.org/10.3390/ijms23010417
  28. Sun Z, Luo D, Wang S, Huang R, Dong P. Salvianolic acid B inhibits myofibroblast differentiation and extracellular matrix accumulation in nasal polyp fibroblasts via the TGF-β1 signaling pathway. Mol Med Rep. 2021;23(6):478.  https://doi.org/10.3892/mmr.2021.12117
  29. Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449-1456.e4.  https://doi.org/10.1016/j.jaci.2015.12.1324
  30. Morawska-Kochman M, Śmieszek A, Marcinkowska K, Marycz KM, Nelke K, Zub K, Zatoński T, Bochnia M. Expression of apoptosis-related biomarkers in inflamed nasal sinus epithelium of patients with chronic rhinosinusitis with nasal polyps (CRSwNP)-evaluation at mRNA and miRNA levels. Biomedicines. 2022;10(6):1400. https://doi.org/10.3390/biomedicines10061400
  31. Ryu G, Kim DW. Th2 inflammatory responses in the development of nasal polyps and chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2020;20(1):1-8.  https://doi.org/10.1097/ACI.0000000000000588
  32. Roan F, Obata-Ninomiya K, Ziegler SF. Epithelial cell-derived cytokines: more than just signaling the alarm. J Clin Invest. 2019;129(4):1441-1451. https://doi.org/10.1172/JCI124606
  33. Kim HJ, Park JH, Shin JM, Yang HW, Lee HM, Park IH. TGF-β1-induced HSP47 regulates extracellular matrix accumulation via Smad2/3 signaling pathways in nasal fibroblasts. Sci Rep. 2019;9(1):15563. https://doi.org/10.1038/s41598-019-52064-1
  34. Sadek AA, Abdelwahab S, Eid SY, Almaimani RA, Althubiti MA, El-Readi MZ. Overexpression of inducible nitric oxide synthase in allergic and nonallergic nasal polyp. Oxid Med Cell Longev. 2019;2019:7506103. https://doi.org/10.1155/2019/7506103
  35. Hu H, Wang S, Wang J, Huang R, Dong P, Sun Z. uPA affects the CRSsNP nasal mucosa epithelium apoptosis by regulating WIF1. Exp Cell Res. 2019;377(1-2):75-85.  https://doi.org/10.1016/j.yexcr.2018.12.024
  36. Xu X, Lai Y, Hua ZC. Apoptosis and apoptotic body: disease message and therapeutic target potentials. Biosci Rep. 2019;39(1):BSR 20180992. https://doi.org/10.1042/BSR20180992
  37. Wang C, Zhou ML, Liu YC, Cheng KJ. The roles of autophagy, mitophagy, and the akt/mTOR pathway in the pathogenesis of chronic rhinosinusitis with nasal polyps. J Immunol Res. 2022;2022:2273121. https://doi.org/10.1155/2022/2273121
  38. Dubikov AI, Kalinichenko SG, Matveeva NYu. Apoptoz kak faktor organizatsii autoimmunnogo vospaleniya pri revmatoidnom artrite. Sovremennaya Revmatologiya. 2019;3(3):95-101. (In Russ.). https://doi.org/10.14412/1996-7012-2019-3-95-101
  39. Kim JY, Lim S, Lim HS, et al. Bone morphogenetic protein-2 as a novel biomarker for refractory chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2021;148(2):461-472.e13.  https://doi.org/10.1016/j.jaci.2021.02.027
  40. Chiarella E, Lombardo N, Lobello N, Aloisio A, Aragona T, Pelaia C, Scicchitano S, Bond HM, Mesuraca M. Nasal polyposis: insights in epithelial-mesenchymal transition and differentiation of polyp mesenchymal stem cells. Int J Mol Sci. 2020;21(18):6878. https://doi.org/10.3390/ijms21186878
  41. Bae JS, Ryu G, Kim JH, et al. Effects of Wnt signaling on epithelial to mesenchymal transition in chronic rhinosinusitis with nasal polyp. Thorax. 2020;75(11):982-993.  https://doi.org/10.1136/thoraxjnl-2019-213916
  42. Pappa V, Spitsin S, Gaskill PJ, Douglas SD. Neurokinin-1 receptor signaling induces a pro-inflammatory transcriptomic profile in CD16+ monocytes. J Neuroimmunol. 2021;353:577524. https://doi.org/10.1016/j.jneuroim.2021.577524
  43. Mullol J, Azar A, Buchheit KM, Hopkins C, Bernstein JA. Chronic rhinosinusitis with nasal polyps: quality of life in the biologics era. J Allergy Clin Immunol Pract. 2022;10(6):1434-1453.e9.  https://doi.org/10.1016/j.jaip.2022.03.002
  44. Chen CC, Buchheit KM. Endotyping chronic rhinosinusitis with nasal polyps: understanding inflammation beyond phenotypes. Am J Rhinol Allergy. 2023;37(2):132-139.  https://doi.org/10.1177/19458924221149003
  45. Savlevich EL, Lyubimova EV, Zurochka AV, Mitrofanova ES, Shilovskii IP. Tsitokinovyi profil’ tkani nosovykh polipov i klinicheskaya kharakteristika patsientov s raznoi stepen’yu medikamentoznogo kontrolya i tyazhesti techeniya polipoznogo rinosinusita Meditsinskaya Immunologiya. 2024;26(3):533-544. (In Russ.). https://doi.org/10.15789/1563-0625-CPO-2914
  46. Gokani SA, Espehana A, Pratas AC, Luke L, Sharma E, Mattock J, Gavrilovic J, Clark A, Wileman T, Philpott CM. Systematic review of protein biomarkers in adult patients with chronic rhinosinusitis. Am J Rhinol Allergy. 2023;37(6):705-729.  https://doi.org/10.1177/19458924231190568
  47. Seah JJ, Thong M, Wang Y. The diagnostic and prognostic role of biomarkers in chronic rhinosinusitis. Diagnostics (Basel). 2023;13(4):715.  https://doi.org/10.3390/diagnostics13040715
  48. Yamada T, Miyabe Y, Ueki S, et al. Eotaxin-3 as a plasma biomarker for mucosal eosinophil infiltration in chronic rhinosinusitis. Front Immunol. 2019;10:74.  https://doi.org/10.3389/fimmu.2019.00074
  49. Zhang F, Xu Z, He X, Sun Y, Zhao C, Zhang J. Increased B cell-activating factor expression is associated with postoperative recurrence of chronic rhinosinusitis with nasal polyps. Mediators Inflamm. 2022;2022:7338692. https://doi.org/10.1155/2022/7338692
  50. Wang G, Li M, Zheng J, Zhan J, Zheng H, Li R, Wei X. Circulating BAFF as novel biomarker in distinguishing chronic rhinosinusitis with nasal polyps endotypes and predicting postoperative recurrence. Int Immunopharmacol. 2022;104:108515. https://doi.org/10.1016/j.intimp.2021.108515
  51. Porfire Irimia IM, Berindan-Neagoe I, Budisan L, Leucuta DC, Gata A, Minoiu AC, Georgescu BA, Covaliu BF, Albu S. Tissue interleukin-33: a novel potential regulator of innate immunity and biomarker of disease severity in chronic rhinosinusitis with nasal polyps. J Clin Med. 2023;12(24):7537. https://doi.org/10.3390/jcm12247537
  52. Wang G, Zheng H, Chen X, Zheng J, Zhan J, Li R, Qi Y, Ye Y, Zeng M, Wei X. Exploration of predictive biomarkers for postoperative recurrence in chronic rhinosinusitis with nasal polyps based on serum multiple-cytokine profiling. Mediators Inflamm. 2022;2022:1061658. https://doi.org/10.1155/2022/1061658

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.